Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
Kathy Giusti | Photograph courtesy of the Multiple Myeloma Research Foundation
You might also like
FAS Reports Financial Stability, But Rising Debt
Leaders say the cost of consultants and severance will be recouped within 18 months.
Judge Dismisses Case Demanding Harvard Admissions Data
The government failed to meet procedural requirements before suing the University.
Harvard Graduate Workers Begin Strike
In the second walkout in six months, union leaders call for better pay and benefits and a stronger grievance process.
Most popular
Explore More From Current Issue
These newly released novels, histories, and memoirs grapple with identity in all its forms.
The professor and former Harvard College dean is the next president of Harvard Magazine’s Board of Directors
As humanities shrink across higher education, one department is flourishing. Is its success a fluke, or a roadmap?